Three specific antigens to isolate endothelial progenitor cells from human liposuction material

Area of Science:

• Regenerative Medicine
• Cell Biology
• Vascular Biology

Background:

• Endothelial progenitor cells (EPCs) are vital for neovascularization and regenerative medicine.
• Current methods for EPC enrichment from peripheral blood, cord blood, and bone marrow are established.
• Isolating EPCs from human adipose tissue presents significant challenges due to their rarity.

Purpose of the Study:

• To develop and validate a method for enriching endothelial progenitor cells (EPCs) from human adipose tissue.
• To characterize the isolated EPCs for specific markers and functional capabilities.
• To assess the potential of adipose-derived EPCs in regenerative medicine applications.

Main Methods:

• Adipose tissue was processed via collagenase digestion to obtain the stromal vascular fraction (SVF).
• Magnetic cell sorting using CD133, CD34, and CD31 microbeads was employed for EPC enrichment.
• Flow cytometry, Matrigel assay, and acetylated low-density lipoprotein uptake were used for cell characterization and functional assessment.

Main Results:

• Stromal vascular fraction (SVF) showed heterogeneous cell populations with rare CD133+ cells.
• Enriched EPCs exhibited cobblestone morphology and expressed key endothelial markers (CD31, CD144, VEGFR2, CD146, CD73, CD105).
• Functional assays confirmed EPCs' ability to uptake acetylated low-density lipoprotein and form tube-like structures on Matrigel.

Conclusions:

• A combination of CD133, CD34, and CD31 magnetic microbeads effectively enriches rare EPCs from human adipose tissue.
• Adipose-derived EPCs differentiate into endothelial cells in culture.
• These enriched EPCs hold potential for neovascularization in regenerative medicine therapies.